These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16780378)

  • 1. Structural differences between wild-type and fish eye disease mutant of lecithin:cholesterol acyltransferase.
    Reshetnyak Y; Tchedre KT; Nair MP; Pritchard PH; Lacko AG
    J Biomol Struct Dyn; 2006 Aug; 24(1):75-82. PubMed ID: 16780378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein.
    O K; Hill JS; Wang X; Pritchard PH
    J Lipid Res; 1993 Jan; 34(1):81-8. PubMed ID: 8445345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lecithin: cholesterol acyltransferase (LCAT)--the genetic analysis of familial LCAT deficiency and fish eye disease].
    Bujo H; Saito Y
    Nihon Rinsho; 1995 May; 53(5):1260-6. PubMed ID: 7602789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fish eye syndrome: a molecular defect in the lecithin-cholesterol acyltransferase (LCAT) gene associated with normal alpha-LCAT-specific activity. Implications for classification and prognosis.
    Klein HG; Santamarina-Fojo S; Duverger N; Clerc M; Dumon MF; Albers JJ; Marcovina S; Brewer HB
    J Clin Invest; 1993 Jul; 92(1):479-85. PubMed ID: 8326012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of two novel mutations in a pedigree with familial lecithin:cholesterol acyltransferase deficiency: structure-function relationships and studies in a compound heterozygous proband.
    Argyropoulos G; Jenkins A; Klein RL; Lyons T; Wagenhorst B; St Armand J; Marcovina SM; Albers JJ; Pritchard PH; Garvey WT
    J Lipid Res; 1998 Sep; 39(9):1870-6. PubMed ID: 9741700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catalytically inactive lecithin: cholesterol acyltransferase (LCAT) caused by a Gly 30 to Ser mutation in a family with LCAT deficiency.
    Yang XP; Inazu A; Honjo A; Koizumi I; Kajinami K; Koizumi J; Marcovina SM; Albers JJ; Mabuchi H
    J Lipid Res; 1997 Mar; 38(3):585-91. PubMed ID: 9101439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase.
    Holleboom AG; Kuivenhoven JA; van Olden CC; Peter J; Schimmel AW; Levels JH; Valentijn RM; Vos P; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Hollak CE
    Atherosclerosis; 2011 May; 216(1):161-5. PubMed ID: 21315357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.
    Vanloo B; Peelman F; Deschuymere K; Taveirne J; Verhee A; Gouyette C; Labeur C; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2000 May; 41(5):752-61. PubMed ID: 10787436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
    Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
    Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K).
    Adimoolam S; Jin L; Grabbe E; Shieh JJ; Jonas A
    J Biol Chem; 1998 Dec; 273(49):32561-7. PubMed ID: 9829992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disturbed apolipoprotein A-I-containing lipoproteins in fish-eye disease are improved by the lecithin:cholesterol acyltransferase produced by gene-transduced adipocytes in vitro.
    Asada S; Kuroda M; Aoyagi Y; Bujo H; Tanaka S; Konno S; Tanio M; Ishii I; Aso M; Saito Y
    Mol Genet Metab; 2011 Feb; 102(2):229-31. PubMed ID: 21074466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
    Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
    J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.
    Manthei KA; Yang SM; Baljinnyam B; Chang L; Glukhova A; Yuan W; Freeman LA; Maloney DJ; Schwendeman A; Remaley AT; Jadhav A; Tesmer JJ
    Elife; 2018 Nov; 7():. PubMed ID: 30479275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation (Asn5-->Ile) in lecithin: cholesterol acyltransferase (LCAT) gene in a Japanese patient with LCAT deficiency.
    Okubo M; Aoyama Y; Shio H; Albers JJ; Murase T
    Int J Clin Lab Res; 1996; 26(4):250-4. PubMed ID: 9007616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?
    Rousset X; Shamburek R; Vaisman B; Amar M; Remaley AT
    Curr Atheroscler Rep; 2011 Jun; 13(3):249-56. PubMed ID: 21331766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.